Sara van den Berg

39 2 CMV on influenza vaccination 21. McElhaney, J.E., The unmet need in the elderly: How immunosenescence, CMV infection, co- morbidities and frailty are a challenge for the development of more effective influenza vaccines. European Geriatric Medicine, 2012. 3: p. S21-S22. 22. Saurwein-Teissl, M., et al., Lack of antibody production following immunization in old age: association with CD8(+)CD28(-) T-cell clonal expansions and an imbalance in the production of Th1 and Th2 cytokines. J Immunol, 2002. 168(11): p. 5893-9. 23. Wald, A., et al., Impact of human cytomegalovirus (CMV) infection on immune response to pandemic 2009 H1N1 influenza vaccine in healthy adults. J Med Virol, 2013. 85(9): p. 1557-60. 24. Turner, J.E., et al., Rudimentary signs of immunosenescence in Cytomegalovirus-seropositive healthy young adults. Age (Dordr), 2014. 36(1): p. 287-97. 25. Trzonkowski, P., et al., Association between cytomegalovirus infection, enhanced proinflammatory response and low level of anti-hemagglutinins during the anti-influenza vaccination--an impact of immunosenescence. Vaccine, 2003. 21(25-26): p. 3826-36. 26. Frasca, D., et al., Cytomegalovirus (CMV) seropositivity decreases B cell responses to the influenza vaccine. Vaccine, 2015. 33(12): p. 1433-9. 27. Derhovanessian, E., et al., Latent infection with cytomegalovirus is associated with poor memory CD4 responses to influenza A core proteins in the elderly. J Immunol, 2014. 193(7): p. 3624-31. 28. Alonso Arias, R., et al., Intensity of the humoral response to cytomegalovirus is associated with the phenotypic and functional status of the immune system. J Virol, 2013. 87(8): p. 4486-95. 29. den Elzen, W.P., et al., Cytomegalovirus infection and responsiveness to influenza vaccination in elderly residents of long-term care facilities. Vaccine, 2011. 29(29-30): p. 4869-74. 30. Haq, K., et al., Cytomegalovirus Seropositivity Predicts a Decline in the T-cell But Not the Antibody Response to Influenza in Vaccinated Older Adults Independent of Type 2 Diabetes Status. J Gerontol A Biol Sci Med Sci, 2016. 31. Furman, D., et al., Cytomegalovirus infection enhances the immune response to influenza. Sci Transl Med, 2015. 7(281): p. 281ra43. 32. Strindhall, J., et al., Humoral response to influenza vaccination in relation to pre-vaccination antibody titres, vaccination history, cytomegalovirus serostatus and CD4/CD8 ratio. Infect Dis (Lond), 2016. 48(6): p. 436-42. 33. McElhaney, J.E., et al., Predictors of the antibody response to influenza vaccination in older adults with type 2 diabetes. BMJ Open Diabetes Res Care, 2015. 3(1): p. e000140. 34. Mosterin Hopping, A., et al., The confounded effects of age and exposure history in response to influenza vaccination. Vaccine, 2016. 34(4): p. 540-6. 35. Beyer, W.E., et al., Effects of repeated annual influenza vaccination on vaccine sero-response in young and elderly adults. Vaccine, 1996. 14(14): p. 1331-9. 36. Michel, J.P. and P.O. Lang, Promoting life course vaccination. Rejuvenation Res, 2011. 14(1): p. 75-81. 37. Lang, P.O. and R. Aspinall, Immunosenescence and herd immunity: with an ever-increasing aging population do we need to rethink vaccine schedules? Expert Rev Vaccines, 2012. 11(2): p. 167-76. 38. Miller, E., et al., Incidence of 2009 pandemic influenza A H1N1 infection in England: a cross-sectional serological study. Lancet, 2010. 375(9720): p. 1100-8. 39. Luytjes, W., et al., HI responses induced by seasonal influenza vaccination are associated with clinical protection and with seroprotection against non-homologous strains. Vaccine, 2012. 30(35): p. 5262-9. 40. Zeger, S.L. and K.Y. Liang, Longitudinal data analysis for discrete and continuous outcomes. Biometrics, 1986. 42(1): p. 121-30.